XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2

Note 8 - Accrued Expenses and Other Liabilities

6 Months Ended

Jun. 30, 2021

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

		June 30, 2021				December 31, 2020
Compensation and related expenses		$	7,754			$	7,345
Professional fees			2,542				3,438
Operating lease liability - current			1,524				1,437
Clinical trial costs			2,604				1,429
Other			1,972				1,144
Total		$	16,396			$	14,793

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration